Abstract:Park et al1Park S.W. Lee K.J. Chung M.J. et al.Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial.Gastrointest Endosc. 2023; 97: 132-142.e2Abstract Full Text Full Text PDF Scopus (2) Google Scholar reported no significant differences in the 6-month stent patency rates and mortality between partially covered and uncovered double bare self-expandable metal stents (PCDBSs vs UCDBSs) for unresectable distal malignant biliary obstruction. This randomized controlled multicenter trial is of great significance for clinical practice, yet we would like to share our reservations for further research. First, as shown in the baseline characteristics section, the length of the stricture was longer in PCDBSs than in UCDBSs (2.8 ± 1.3 vs 2.4 ± 1.2, P = .010). The length or the degree of stricture might be correlated with disease severity and stent patency,2Kim H.S. Lee D.K. Kim H.G. et al.Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study.Gastrointest Endosc. 2002; 55: 359-365Abstract Full Text Full Text PDF PubMed Scopus (92) Google Scholar and longer biliary stricture was an independent risk factor for worse survival after metal stent insertion,3Zu Q.Q. Zhang J.X. Wang B. et al.Percutaneous transpapillary biliary stent placement for distal malignant biliary obstruction: outcomes and survival analysis.Turk J Gastroenterol. 2019; 30: 714-721Crossref Scopus (5) Google Scholar which is also in accord with the fact that the rate of tumor overgrowth was higher in the PCDBS group than in the UCDBS group (5.5% vs 0.8%). Therefore, we hypothesize that the PCDBS group had selection bias, which would weaken the effect of PCDBSs on stent patency and overall survival, and a propensity-matching analysis may be required. Second, we would like to know whether there was a significant difference in the total incidence of single adverse events between the 2 groups, regardless of the 2-week time limit, so as to better verify the overall impact of whether or not the novel metal stent is covered on the risk of adverse events.4Dumonceau J.M. Kapral C. Aabakken L. et al.ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline.Endoscopy. 2020; 52: 127-149Crossref PubMed Scopus (331) Google Scholar Third, the authors did not disclose the details of revision for stent dysfunction, which might have had some influence on stent patency and overall survival. For example, radiofrequency ablation can be performed by both endoscopic and percutaneous routes. As a novel adjunctive procedure and a promising therapeutic option in patients with malignant biliary obstruction, radiofrequency ablation can achieve local tumor control, resulting in improved biliary stent patency and a potential survival benefit.5Inoue T. Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction.Dig Endosc. 2022; 34: 345-358Crossref PubMed Scopus (22) Google Scholar Both authors disclosed no financial relationships.

Effect of modified biopsy forceps on the diagnosis of malignant biliary strictures: A randomized controlled trial

The Diagnostic Accuracy of Conventional Forceps Biopsy Compared to ESD.

Percutaneous transhepatic cholangiography versus endoscopic retrograde cholangiography for the pathological diagnosis of suspected malignant bile duct strictures

A comparative study on the application of different endoscopic diagnostic methods in the differential diagnosis of benign and malignant bile duct strictures

Tissue Sampling through Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Endoscopic Retrograde Cholangiopancreatographic Brushing Cytology Technique in Suspicious Malignant Biliary Stricture

Tissue acquisition for diagnosis of biliary strictures using peroral cholangioscopy or endoscopic ultrasound-guided fine-needle aspiration

Diagnostic efficacy of a novel rotating brush for endoscopic sampling of malignant biliary strictures: a multicenter prospective study

EUS- Versus ERCP-guided Biliary Drainage for Malignant Biliary Obstruction: Evidence from Randomized Controlled Studies

The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancer

Current Status and Evaluation of Endoscopic Treatment of Biliary Strictures

Efficacy and Safety of Digital Single-Operator Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures by Targeted Biopsies: A Systematic Review and Meta-Analysis

False-negative factors of percutaneous transluminal clamp biopsy for suspected malignant biliary stricture: 194 cases analyzed from a single center

A Unique Approach to Obtaining Tissue in a Difficult to Access Indeterminate Biliary Stricture: Percutaneous Cholangioscopy and Biopsy

Effect of single operator cholangioscopy on accuracy of bile duct cytology

Comparative Efficacy of Brush Cytology and Forceps Biopsy in the Diagnosis of Malignant Biliary Strictures: A Single-Center Study in Pakistan

Digital single-operator cholangioscopy for biliary stricture after cadaveric liver transplantation

Determining the Indeterminate Biliary Stricture: Cholangioscopy and Beyond

Clinical impact of digital cholangioscopy in management of indeterminate biliary strictures and complex biliary stones: a single-center study

Accuracy of Brush Cytology in Biliopancreatic Strictures: a Single-Center Cohort Study.

Laparoscopic Choledocholithotomy with a Novel Articulating Forceps.

Double Bare Self-Expandable Metal Stent for Distal Malignant Biliary Obstruction.